Patients were maintained on a stable, therapeutically optimal dosage and schedule of levadopa-carbidopa (Sinemet) throughout the study
Parkinson's disease is a disorder of the central nervous system (brain and spinal cord)
The present study suggests that levodopa might prevent a decline in cognitive function in non-demented patients with PD
Sinemet® Sinemet® is one of the most widely prescribed treatments for Parkinson's disease
Sinemet is approved to treat parkinsonism that develops after: encephalitis (swelling of your brain) carbon monoxide poisoning; manganese toxicity Mild cognitive impairment (MCI) is a change in thinking or memory that is more than expected with normal aging but is not enough to interfere with a person’s daily activities
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle
However, agents such as Sinemet may also interfere with cognitive processes by disrupting homeostatic neurotransmission, thereby contributing to memory
This could be caused by several factors, such as a decrease in dopamine levels or
Dosage may be increased by one tablet every day or every other day, as necessary, until a dosage of eight tablets of SINEMET 25-100 a day is reached
Patients receiving long-term levodopa therapy must contend with some adverse effects
Written by Jennifer G
Within People with Parkinson’s may experience different types of cognitive changes
et al
lower back or side pain
Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: An initial double-blind placebo-controlled study
Brain Inj 1997;11:455 The clinical trials assessed the effectiveness of Exelon by measuring the change in cognition and the ability to carry out daily tasks compared to the placebo using the Alzheimer’s Disease Assessment Scale-Cognition (ADAS-cog) test, which scores the patient based on a series of questions to measure memory, language skills, and
By far the most commonly used are the “z-drugs” which include zolpidem, zaleplon, and eszopiclone (brand names Ambien, Sonata, and Lunesta, respectively)
The cognitive portion of the ADAS assesses orientation, memory, language, visuospatial, and praxis functions
Patients with atypical Parkinsonism often have some degree of difficulty speaking or swallowing, and drooling can be a problem
This is typically the first formulation to be tried when someone is started on levodopa treatment
sticking out of tongue
Use of the older ‘typical’ antipsychotic drugs led to worsening of motor symptoms